Shares of INOVIO (INO) are rising over 14% in pre-market today, after the company announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA vaccine, demonstrating robust neutralizing antibody and T cell immune responses against coronavirus SARS-CoV-2.
from RTT - Before the Bell https://ift.tt/2ToSe5f
via IFTTT
No comments:
Post a Comment